In vivo responses to vincristine
Patient . | EFS (d ± SD) . | |
---|---|---|
Saline control . | Vincristine . | |
2 | 12.6 ± 3.0 | 41.7 ± 7.55-150 |
3 | 7.3 ± 3.9 | 56.7 ± 5.3 |
7 | 7.5 ± 4.1 | 8.3 ± 4.15-150 |
8 | 6.1 ± 2.4 | 34.4 ± 3.85-150 |
17 | 8.5 ± 4.5 | 34.6 ± 4.75-150 |
19 | 5.1 ± 1.7 | 13.6 ± 7.95-150 |
Patient . | EFS (d ± SD) . | |
---|---|---|
Saline control . | Vincristine . | |
2 | 12.6 ± 3.0 | 41.7 ± 7.55-150 |
3 | 7.3 ± 3.9 | 56.7 ± 5.3 |
7 | 7.5 ± 4.1 | 8.3 ± 4.15-150 |
8 | 6.1 ± 2.4 | 34.4 ± 3.85-150 |
17 | 8.5 ± 4.5 | 34.6 ± 4.75-150 |
19 | 5.1 ± 1.7 | 13.6 ± 7.95-150 |
Significantly different from patient 3 (P < .05).